- Investing Ideas
- Chinese Pharmaceuticals & Biotech Healthy high growth potential
Chinese Pharmaceuticals & Biotech Healthy high growth potential
Results
8
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
8 companies
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥28.3b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥60.86
7D
-10.0%
1Y
-13.1%
Shanghai Haoyuan Chemexpress
Market Cap: CN¥15.1b
Engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs.
688131
CN¥71.00
7D
-22.3%
1Y
20.4%
PharmaResources (Shanghai)
Market Cap: CN¥4.7b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥26.50
7D
-18.3%
1Y
-8.4%
AcrobiosystemsLtd
Market Cap: CN¥8.9b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥53.25
7D
-1.2%
1Y
-1.5%
Xiamen Amoytop Biotech
Market Cap: CN¥24.2b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥59.36
7D
1.5%
1Y
-21.9%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥9.1b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥24.83
7D
-2.8%
1Y
-26.1%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥6.8b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥12.47
7D
-18.1%
1Y
-23.5%
Inner Mongolia Furui Medical Science
Market Cap: CN¥11.0b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥41.70
7D
-6.3%
1Y
-0.6%